Literature DB >> 32347403

COVID-19 Pandemic Disrupts HIV Continuum of Care and Prevention: Implications for Research and Practice Concerning Community-Based Organizations and Frontline Providers.

Rogério M Pinto1, Sunggeun Park2.   

Abstract

Entities:  

Year:  2020        PMID: 32347403      PMCID: PMC7186186          DOI: 10.1007/s10461-020-02893-3

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


× No keyword cloud information.
More quickly and more vividly than they could have anticipated, people living with (PLWH) and those at-risk for HIV felt the impact of the COVID-19 pandemic, as they were asked to shelter in place and distance themselves from others. Over the months of March and April 2020, around the time shelter-in-place orders accelerated, community-based organizations (CBOs) have closed, medical offices have cut hours, and medical personnel have shifted from primary care to COVID-19 hospital units. We assess the extent to which the COVID-19 pandemic has disrupted the HIV Continuum of Care and Prevention—that is, testing, pre-exposure prophylaxis (PrEP), and primary care—and propose a course of action so that we may end the HIV epidemic in this decade.

Ending the HIV Epidemic Within this Decade

The United States Department of Health and Human Services has proposed a reduction in the number of HIV infections in the United States by 90% within the current decade [1]. The World Health Organization’s 90/90/90 goal also aims to contain the HIV pandemic by 2030, at which time 90% of all people living with HIV (PLWH) are projected to know their HIV status; 90% with diagnosed HIV infection are projected to receive antiretroviral therapy; and 90% of those receiving antiretroviral therapy are projected to show viral suppression. Ending the HIV pandemic requires that we gather local knowledge on which to base sustainable action. It requires leveraging local efforts led by community-based organizations helping those at high risk for HIV navigate complex diffusion systems and promote health equity—a national priority to improve health access for all, regardless of geographic boundaries, race/ethnicity, and sexual orientation [2, 3]. Community-based organizations (CBOs) employ frontline service providers—social workers, health educators, navigators—to help (1) individuals of unknown HIV status access testing; (2) those at high-risk for HIV but who test negative to access physicians who can prescribe PrEP; (3) those who test positive for HIV to access primary care [4]; and all at-risk clients to access support services to help them stay on the HIV Continuum of Care and Prevention (“care continuum”) [5-8]. Nonetheless, community-engaged research suggests that, prior to the COVID-19 pandemic, these frontline providers had not been consistent in how often or in how they linked clients to care continuum services. Using cross-sectional data from nearly 300 frontline providers in New York City, an epicenter of both the HIV and COVID-19 pandemics, our research shows that, in the six months prior to data collection, 50% of provider participants had linked fewer than five clients to HIV testing; 48% linked fewer than five clients to primary care; and 48% had not provided any client with PrEP education [9]. These numbers are worrisome, but longitudinal data show a brighter picture. We detected increased involvement in at least some service linkage from 76% providers at baseline to 81% over two years [10]. Nearly half (47%) of providers offered PrEP education at both of these time points; 19% started offering PrEP education since baseline; while 5% stopped offering education at follow-up [11]. Furthermore, evidence suggests that frontline providers who more frequently link clients to HIV services tend to do so as part of face-to-face client meetings, at which the provider might ask the client, while still in their presence, to contact the referral, or the provider might make the contact and hand the client written information [12]. This level of proximity is a challenge under the shelter-in-place and physical distancing orders.

COVID-19 is Likely to Impede Ending the HIV Epidemic

Before we crafted this Note from the Field, our CBO partners (i.e. managers and providers) informed us that the COVID-19 pandemic had already disrupted all care continuum services. Physical distancing between providers and clients will likely have a negative impact on how often and how frontline providers will link clients to services. This opens up a field of inquiry needed to develop best practices for referral-making. The COVID-19 pandemic quickly exposed medical (e.g. difficult access to services, lack of testing and insurance), and structural (e.g. unemployment, food insecurity, geographic isolation) vulnerabilities which have also historically undermined individual- and system-level HIV prevention [13]. CBOs are following stay-in-shelter orders and using online platforms and telephones to communicate with clients. Some of these platforms are unreliable, and clients and providers alike may encounter difficulties navigating them; many do not have access to high-speed Internet or have enough of a data allowance on their cellular phone plans. To offer basic information about HIV prevention, CBOs are turning to social media: teaching clients about HIV testing and PrEP; reminding clients of the importance of physical distancing; and providing social support for newly diagnosed individuals. Since access to in-person HIV tests has been hampered, one CBO partner mentioned about their network, “as far as I know, no one is doing any HIV testing right now.” Another CBO offers at-home HIV test kits to high-need clients, but the number of kits available is limited. Frontline providers (e.g., PrEP navigators) are not allowed (confidential HIPAA compliant) to take client information from their offices, thus they have stopped making referrals to physicians who can prescribe PrEP. Providers have cut back on or stopped altogether making referrals to primary care. They are nonetheless providing limited harm reduction and support services, with all parties adhering to physical distancing—for example, clean syringes passed through mobile unit windows and food and other items dropped off in front of clients’ homes. Meanwhile, CBO managers are working on safety protocols and are purchasing protective materials in preparation for resuming face-to-face consultation when the stay-in-shelter order is lifted.

Implications for Practice and Research

The COVID-19 pandemic presents multifaceted challenges to HIV service CBOs, including but not limited to resource shortages, low staff morale, and disruption to patient-centered service provision. Suspending services creates budgetary shortfalls for CBOs that heavily rely on program revenues [14]. Given the skyrocketing numbers of unemployment claims in the last two weeks of March and two first weeks of April [15], many vulnerable clients may not be able to make co-payments for services, even after CBO doors are open again. CBOs expect significant declines in private donations, as also observed in the 2008 recession [16]. Now and during the stay-in-shelter period, CBOs are likely to rely on small business and individual donations and government programs. They are likely to strengthen relationships with private and public partners (e.g., other CBOs) in their communities in order to advocate for more effective government responses such as those initiated in response to the Great Depression of the 1930s [17]. The pandemic has created a substantial decline in provider morale. Many have and will continue to lose colleagues and clients to COVID-19. With limited resources and capacities, they are likely to be forced to make difficult choices as to which cases to prioritize for services [18, 19]. CBO staff will likely face layoffs and/or reduced paychecks as organizations struggle to stay open. These factors will continue to impact negatively frontline providers’ sprit, motivation, and mental health. Providers having day-to-day interactions with clients in primary care, outpatient, and prevention settings are poised to help PLWH and vulnerable individuals overcome HIV-related stigma, PrEP stigma, inadequate health insurance, and can help improve HIV testing rates [20-25]. Provider engagement of clients in referral-making processes seems to improve client access to HIV testing, PrEP, and primary care, even when provider caseloads are high, clients may lack insurance, and CBOs may fear losing clients and revenue to other CBOs [5, 26, 27]. However, in the face of COVID-19, such engaged, face-to-face interactions and referrals might not be feasible. Community-focused research can help track the degree to which COVID-19 is disrupting CBO operations, provider behaviors, and client experiences and outcomes. The disruptions caused by COVID-19 allow us to see how the HIV care continuum has been undermined routinely by insufficient concrete and human organizational resources, and by failures to follow up and track provider referrals to HIV services. To demonstrate how structural failures, highlighted by the COVID-19 pandemic, prevent providers from keeping their clients on the care continuum, we must study how CBOs’ organizational supports incorporate client perspectives. COVID-19 exposed the need for research to understand how high volumes of incomplete referrals—i.e. clients not accessing services to which they are referred—waste time allotted for services, increases costs, lengthen waitlists, and jeopardize health outcomes (e.g., retention in care, viral suppression) [6, 28]. Providers’ active referral-making (including subsequent coordination and tracking efforts) can facilitate clients’ timely access to needed services and reduce waste of organizational resources (e.g., staff hours, social capital) [29]. Despite the growing emphasis on person-centered care [30-33], few empirical studies have investigated the implications of person-centered care for organizations offering HIV services [34-36]. We also need to look at current literature and identify not only gaps but the limitations of past research (e.g. lack of large-scale qualitative evidence and limited involvement of clients and providers). Doing so should help researchers address the limited evidence on referral-making and linkage practices that could help clients access the HIV services to which they are referred (“referral completion”), and, ultimately, end the HIV pandemic within this decade.
  21 in total

1.  Interprofessional Collaboration and On-the-Job Training Improve Access to HIV Testing, HIV Primary Care, and Pre-Exposure Prophylaxis (PrEP).

Authors:  Rogério M Pinto; Susan S Witte; Prema Filippone; C Jean Choi; Melanie Wall
Journal:  AIDS Educ Prev       Date:  2018-12

2.  Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.

Authors:  Shruti H Mehta; Gregory M Lucas; Lisa B Mirel; Michael Torbenson; Yvonne Higgins; Richard D Moore; David L Thomas; Mark S Sulkowski
Journal:  AIDS       Date:  2006-11-28       Impact factor: 4.177

3.  Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?

Authors:  Mary Catherine Beach; Jeanne Keruly; Richard D Moore
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

4.  Interprofessional collaboration improves linkages to primary care: a longitudinal analysis.

Authors:  Rogério M Pinto; Emma Sophia Kay; C Jean Choi; Melanie M Wall
Journal:  AIDS Care       Date:  2019-09-17

5.  Barriers to HIV Care and Treatment Among Participants in a Public Health HIV Care Relinkage Program.

Authors:  Julia C Dombrowski; Jane M Simoni; David A Katz; Matthew R Golden
Journal:  AIDS Patient Care STDS       Date:  2015-03-31       Impact factor: 5.078

6.  Why Physicians Don't Ask: Interpersonal and Intrapersonal Barriers to HIV Testing-Making a Case for a Patient-Initiated Campaign.

Authors:  Monisha Arya; Sajani Patel; Disha Kumar; Micha Yin Zheng; Michael A Kallen; Richard L Street; Kasisomayajula Viswanath; Thomas P Giordano
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-11-23

7.  Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II.

Authors:  Jason A Craw; Lytt I Gardner; Gary Marks; Richard C Rapp; Jeff Bosshart; Wayne A Duffus; Amber Rossman; Susan L Coughlin; DeAnn Gruber; Lauretta A Safford; Jon Overton; Karla Schmitt
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-15       Impact factor: 3.731

8.  HIV Testing, Care Referral, and Linkage to Care Intervals Affect Time to Engagement in Care for Newly Diagnosed HIV-Infected Adolescents in 15 Adolescent Medicine Clinics in the United States.

Authors:  Morgan M Philbin; Amanda E Tanner; Anna DuVal; Jonathan M Ellen; Jiahong Xu; Bill Kapogiannis; Jim Bethel; J Dennis Fortenberry
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

9.  Interprofessional Collaboration Improves the Odds of Educating Patients About PrEP over Time.

Authors:  Rogério M Pinto; Emma Sophia Kay; Melanie M Wall; C Jean Choi
Journal:  J Gen Intern Med       Date:  2020-01-02       Impact factor: 5.128

10.  Recommendations for HIV Screening of Gay, Bisexual, and Other Men Who Have Sex with Men - United States, 2017.

Authors:  Elizabeth A DiNenno; Joseph Prejean; Kathleen Irwin; Kevin P Delaney; Kristina Bowles; Tricia Martin; Amrita Tailor; Gema Dumitru; Mary M Mullins; Angela B Hutchinson; Amy Lansky
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-08-11       Impact factor: 17.586

View more
  40 in total

1.  The serious threat of late presenters HIV-infected patients in the context of the COVID-19 pandemic.

Authors:  Pierluigi Brugnaro; Erika Morelli; Francesca Cattelan; Andrea Petrucci; Francesco Colombo; Sara Caputo; Licia Laurino; Sandro Panese
Journal:  Infez Med       Date:  2022-03-01

2.  What Will It Take to End HIV in the United States? : A Comprehensive, Local-Level Modeling Study.

Authors:  Anthony Todd Fojo; Melissa Schnure; Parastu Kasaie; David W Dowdy; Maunank Shah
Journal:  Ann Intern Med       Date:  2021-09-21       Impact factor: 25.391

3.  Integrated Methods for Applying Critical Race Theory to Qualitative COVID-19 Equity Research.

Authors:  Bita Amani; Alejandra Cabral; Mienah Z Sharif; James Huỳnh; Kia Skrine Jeffers; Shelby A Baptista; Breann McAndrew; Natalie J Bradford; Patanjali de la Rocha; Chandra L Ford
Journal:  Ethn Dis       Date:  2022-07-21       Impact factor: 2.006

4.  Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics.

Authors:  Ruchita Balasubramanian; Parastu Kasaie; Melissa Schnure; David W Dowdy; Maunank Shah; Anthony Todd Fojo
Journal:  J Acquir Immune Defic Syndr       Date:  2022-10-01       Impact factor: 3.771

5.  COVID-19 Telemedicine and Vaccination at an Urban Safety Net HIV Medicine Clinic.

Authors:  Ryan Anson; Aaron Willcott; Will Toperoff; Afsana Karim; Michael Tang; Darcy Wooten; J Tyler Lonergan; Laura Bamford
Journal:  J Nurse Pract       Date:  2022-07-12       Impact factor: 0.826

6.  Impact of COVID-19 pandemic on HIV viremia: a single-center cohort study in northern Italy.

Authors:  Ilaria Izzo; Canio Carriero; Giulia Gardini; Benedetta Fumarola; Erika Chiari; Francesco Castelli; Eugenia Quiros-Roldan
Journal:  AIDS Res Ther       Date:  2021-06-04       Impact factor: 2.250

7.  AIDS Activism and Coronavirus Vaccine Challenge Trials.

Authors:  Nir Eyal; Perry N Halkitis
Journal:  AIDS Behav       Date:  2020-12

8.  When Home is Not a Safe Place: Impacts of Social Distancing Directives on Women Living with HIV.

Authors:  Kalysha Closson; Melanie Lee; Andrew Gibbs; Angela Kaida
Journal:  AIDS Behav       Date:  2020-11

9.  The Trend of Health Service Utilization and Challenges Faced During the COVID-19 Pandemic at Primary Units in Addis Ababa: A Mixed-Methods Study.

Authors:  Tariku Shimels
Journal:  Health Serv Res Manag Epidemiol       Date:  2021-07-08

10.  Telehealth for HIV Care Services in South Carolina: Utilization, Barriers, and Promotion Strategies During the COVID-19 Pandemic.

Authors:  Valerie Yelverton; Shan Qiao; Sharon Weissman; Bankole Olatosi; Xiaoming Li
Journal:  AIDS Behav       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.